Effect of trelagliptin on vascular endothelial functions and serum adiponectin level in patients with type 2 diabetes: a preliminary single-arm prospective pilot study

BACKGROUND: Trelagliptin, an oral DPP-4 inhibitor, which is administered once per week and characterized by a long half-life in blood. The effects of trelagliptin on vascular endothelial functions have not been clarified to date. The objective of the present study was to examine the effects of trela...

Descripción completa

Detalles Bibliográficos
Autores principales: Ida, Satoshi, Murata, Kazuya, Betou, Katunori, Kobayashi, Chiaki, Ishihara, Yuki, Imataka, Kanako, Uchida, Akihiro, Monguchi, Kou, Kaneko, Ryutaro, Fujiwara, Ryoko, Takahashi, Hiroka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096292/
https://www.ncbi.nlm.nih.gov/pubmed/27809903
http://dx.doi.org/10.1186/s12933-016-0468-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096292/
https://www.ncbi.nlm.nih.gov/pubmed/27809903
http://dx.doi.org/10.1186/s12933-016-0468-4

Ejemplares similares